NetworkNewsBreaks – EVIO, Inc. (EVIO) Expands in
Post# of 2022
EVIO’s (OTCQB: EVIO) Canadian subsidiary, EVIO Canada, recently finalized a 50% acquisition of Keystone Labs, Inc., a Health Canada-licensed medical cannabis testing facility. An article discussing the company reads: “EVIO Inc. (OTCQB: EVIO) reached a significant milestone in its expansion plans in early May when its new subsidiary, EVIO Canada, announced its acquisition of a 50 percent stake in Keystone Labs, Inc., a licensed Canadian testing laboratory specializing in quality testing for regulated industries such as cannabis. In a May 3, 2018, news release announcing the deal (http://nnw.fm/Vr16H), William Waldrop, CEO and co-founder of EVIO, said Keystone Labs fits perfectly within the company’s expansion plans.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer